Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Rheologics to become KKS:

This article was originally published in Clinica

Executive Summary

Developer of devices for the diagnosis and treatment of vascular disease Rheologics Technologies is to change its name to KKS Venture Management, in line with the company's shift towards diversifying in order to improve its cash flow. The Exton, Pennsylvania-based company will continue its research into cardiovascular disease, but has chosen to transition into revenue-generating products, and will function as a venture holding company in a bid to preserve value for its shareholders. KKS' new trading symbol is "KKSV".

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT049323

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel